🔎 Trials Near Me

Akèy › Sipwa › Michigan › Troy

Etid klinik pou Sipwa nan Troy, MI

8 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Troy (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Ap rekriteFaz 3
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07794579

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589608

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Ap rekriteFaz 3
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT06143956

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Ap rekriteFaz 3
  • Arcturus Healthcare, Public Limited Company, Troy Internal Medicine Research Division, Troy
Laj 18 a 99 · Tout sèks · Mizajou Aug 27, 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Ap rekriteFaz 3
  • Research Site, Troy
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07784725

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Ap rekriteFaz 3
  • Arcturus Healthcare, PLC., Troy
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07509307

Etid Sipwa nan lòt vil

Lòt etid nan Troy

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.